Phase I/II study of in vivo angiostatin generation with tissue plasminogen activator (tPA) [alteplase] and captopril in patients with progressive metastatic cancer.
Phase of Trial: Phase I/II
Latest Information Update: 08 Jun 2012
At a glance
- Drugs Alteplase (Primary) ; Captopril (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Feb 2011 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
- 24 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.